Andy is a seasoned attorney and business advisor with 20 years of experience in a variety of industry sectors. Combining deep, hand-on industry knowledge and sophisticated legal skills, he has advised multinational companies such as Pfizer, Celgene, Takeda, Qiagen, etc, on matters from merger and acquisition, technology in and out licensing, business valuation, patent strategies, and patent and business litigations. He has also represented emerging technology companies such as Netlist, Sirona Genomics, Omicsoft, etc., in business transactions and patent and commercial litigations. He has successfully represented clients in patent litigation in multiple federal district courts and the United States International Trade Commission. Andy is licensed in New York, New Jersey, Massachusetts, Texas, and District of Columbia.

​

Education:

Northwestern University, JD

North Carolina State University, PhD Bioinformatics and Statistics

University of Science and Technology of China, BS